Evidence map›Paper›PMID 39372191›Full record

ArticleProgress in rehabilitation medicine2024

A Pilot Trial of Telerehabilitation for Chronic Stroke Survivors: A Case-series Study of Three Individuals.

Ren Fujii, Takaki Tateishi, Shinichiro Tanaka

Abstract readCase Reports
In one paragraph

Article in Progress in rehabilitation medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ren FujiiMusashigaoka Clinical Research Center, Musashigaoka Hospital (Tanakakai Medical Corp.), Kumamoto, Japan.
Takaki TateishiMusashigaoka Clinical Research Center, Musashigaoka Hospital (Tanakakai Medical Corp.), Kumamoto, Japan.
Shinichiro TanakaMusashigaoka Clinical Research Center, Musashigaoka Hospital (Tanakakai Medical Corp.), Kumamoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We designed a telerehabilitation (TR) program for stroke patients based on reports from other countries and adapted the program for use by individual patients. Herein, we describe the clinical courses of three stroke survivors who used the TR program. Cases: All three individuals were community-dwelling chronic stroke survivors. Patient 1 (P1) was a 50-year-old man who presented with severe paralysis of the right upper and lower extremities caused by left cerebral hemorrhage. Patient 2 (P2) was a 56-year-old woman who presented with severe paralysis of the left upper and lower extremities caused by right cerebral hemorrhage. Patient 3 (P3) was a 55-year-old man who presented with severe paralysis of the left upper and lower extremities caused by right cerebral hemorrhage. The TR program was conducted through a web conference system that allowed therapists and patients to interact with each other. The intervention consisted of 30-min sessions every 2 weeks for 6 months. The clinical courses and outcomes of the patients differed, but we identified positive changes in physical activity (number of steps) and participation (expansion of life-space) in addition to improvements in functional impairments (e.g., motor paralysis and balance order) in each patient. All three patients were highly satisfied with the TR program. Discussion: The results observed in this case series suggest that TR programs are a viable intervention in Japan. TR programs can reduce barriers to continued rehabilitation after discharge and can encourage increased activity and participation.

Indexed as

case seriespilot trialpost-stroketelerehabilitation

Identifiers

PMID39372191
PMCPMC11450272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.